Real-world effectiveness of tirzepatide in individuals with obesity: weight response, treatment-related factors and diabetes status
People using tirzepatide for obesity lose weight in routine practice, though prior exposure to related drugs reduces effectiveness in some patients.
This multicenter study followed 588 adults receiving tirzepatide in routine practice. Weight loss differed by diabetes status, and prior exposure to a related drug class was independently associated with less weight reduction.
What the study was
- Study design
- Retrospective multicenter cohort
- Population
- Adults with overweight or obesity treated with tirzepatide
- Sample size
- 588
- Category
- Treatment Innovation
- Maturity
- Validated
- Journal
- Diabetes & metabolism
Why it surfaced
Real-world treatment-effect modifiers are clinically useful, but the retrospective design limits causal inference.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.